Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9465 - 9472 of 12089 results

Second Circuit Holds "Hard Switch" Violates Sherman Act
June 4, 2015| Blog| Viewpoint

The Federal Circuit’s First Foray into the BPCIA: “A Pulitzer Prize for Complexity"?
June 4, 2015| Blog| Viewpoint

Fingerprint-Based Background Checks Begin August 1st for Medicaid Providers
June 4, 2015| Blog| Viewpoint

Injunction Blocks Implementation of Texas Telemedicine Regulations
June 4, 2015| Blog| Viewpoint

OIG Releases Semiannual Report to Congress
June 3, 2015| Blog| Viewpoint

Supreme Court Decides Qui Tam First-to-File Issues
June 3, 2015| Blog| Viewpoint

ML Strategies: Health Care Update & Telehealth Policy Alert
June 3, 2015| Blog| Viewpoint

Home Depot Moves to Dismiss Consumer Data Breach Claims for Lack of Standing
June 3, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
